» Articles » PMID: 28167629

IL-10 Plays Opposing Roles During Systemic and Localized Infections

Overview
Journal J Immunol
Date 2017 Feb 8
PMID 28167629
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

IL-10 is a potent anti-inflammatory mediator that plays a crucial role in limiting host immunopathology during bacterial infections by controlling effector T cell activation. has previously been shown to manipulate the IL-10 response as a mechanism of immune evasion during chronic systemic and biofilm models of infection. In the present study, we demonstrate divergent roles for IL-10 depending on the site of infection. During acute systemic infection, IL-10 plays an important protective role and is required to prevent bacterial dissemination and host morbidity by controlling effector T cells and the associated downstream hyperactivation of inflammatory phagocytes, which are capable of host tissue damage. CD19CD11bCD5 B1a regulatory cells were shown to rapidly express IL-10 in a TLR2-dependent manner in response to , and adoptive transfer of B1a cells was protective during acute systemic infection in IL-10-deficient hosts. In contrast, during localized s.c. infection, IL-10 production plays a detrimental role by facilitating bacterial persistence via the same mechanism of controlling proinflammatory T cell responses. Our findings demonstrate that induction of IL-10 has a major influence on disease outcome during acute infection. Too much IL-10 at one end of the scale may suppress otherwise protective T cell responses, thus facilitating persistence of the bacteria, and at the other end, too little IL-10 may tend toward fatal host-mediated pathology through excessive activation of T cells and associated phagocyte-mediated damage.

Citing Articles

Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia.

Bergersen K, Zheng Y, Rossetti M, Ruffin F, Pickering H, Parmar R BMC Infect Dis. 2025; 25(1):231.

PMID: 39966757 PMC: 11834594. DOI: 10.1186/s12879-025-10620-3.


Pathobiont-induced suppressive immune imprints thwart T cell vaccine responses.

Hajam I, Tsai C, Gonzalez C, Caldera J, Lazaro Diez M, Du X Nat Commun. 2024; 15(1):10335.

PMID: 39681568 PMC: 11649901. DOI: 10.1038/s41467-024-54644-w.


The mononuclear phagocyte system obscures the accurate diagnosis of infected joint replacements.

Manasherob R, Warren S, Arora P, Heo L, Haddock N, Koliesnik I J Transl Med. 2024; 22(1):1041.

PMID: 39563367 PMC: 11575056. DOI: 10.1186/s12967-024-05866-5.


Type 1 interferons promote Staphylococcus aureus nasal colonization by inducing phagocyte apoptosis.

Vozza E, Kelly A, Daly C, ORourke S, Carlile S, Morris B Cell Death Discov. 2024; 10(1):403.

PMID: 39271670 PMC: 11399434. DOI: 10.1038/s41420-024-02173-2.


A loss of function mutation in SOCS2 results in increased inflammatory response of macrophages to TLR ligands and .

Guzylack-Piriou L, Gausseres B, Tasca C, Hassel C, Tabouret G, Foucras G Front Immunol. 2024; 15:1397330.

PMID: 39185412 PMC: 11341364. DOI: 10.3389/fimmu.2024.1397330.


References
1.
Crane D, Griffin A, Wehrly T, Bosio C . B1a cells enhance susceptibility to infection with virulent Francisella tularensis via modulation of NK/NKT cell responses. J Immunol. 2013; 190(6):2756-66. PMC: 3594638. DOI: 10.4049/jimmunol.1202697. View

2.
Foster T . Immune evasion by staphylococci. Nat Rev Microbiol. 2005; 3(12):948-58. DOI: 10.1038/nrmicro1289. View

3.
Gresham H, Lowrance J, Caver T, Wilson B, Cheung A, Lindberg F . Survival of Staphylococcus aureus inside neutrophils contributes to infection. J Immunol. 2000; 164(7):3713-22. DOI: 10.4049/jimmunol.164.7.3713. View

4.
Tzianabos A, Wang J, Lee J . Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc Natl Acad Sci U S A. 2001; 98(16):9365-70. PMC: 55426. DOI: 10.1073/pnas.161175598. View

5.
Pfau J, Hurley K, Peterson C, Coker L, Fowers C, Marcum R . Activation and trafficking of peritoneal B1a B-cells in response to amphibole asbestos. J Immunotoxicol. 2013; 11(1):90-8. DOI: 10.3109/1547691X.2013.796024. View